Fate Therapeutics, Inc. Competitors

FATE 
$1.84
*  
0.12
6.12%
Get FATE Alerts
*Delayed - data as of Apr. 29, 2016 12:12 ET  -  Find a broker to begin trading FATE now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    FATE Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Competitor Industry: Biotechnology: Biological Products (No Diagnostic Substances)

Fate Therapeutics, Inc.

CompanyName
Symbol: Market
LastSale ▼ NetChange Volume Today's High / Low 52 Weeks High / Low P / E Ratio Market Cap
Biogen Inc.
BIIB: NASDAQ-GS
$ 271.90 -9.18 ▼ 842,908 $ 280.53
$ 271.395
$ 420.99
$ 242.07
16.7 59,457,189
Amgen Inc.
AMGN: NASDAQ-GS
$ 156.76 -3.80 ▼ 2,581,265 $ 161.92
$ 156.381
$ 181.81
$ 130.09
16.57 117,897,785
China Biologic Products, Inc.
CBPO: NASDAQ-GS
$ 115.26 -4.73 ▼ 72,293 $ 120.52
$ 114.4501
$ 144.2899
$ 80.60
35.25 3,064,879
Bio-Techne Corp
TECH: NASDAQ-GS
$ 92.50 -0.06 ▼ 77,784 $ 93.44
$ 91.45
$ 114.56
$ 79.95
34.77 3,440,168
Gilead Sciences, Inc.
GILD: NASDAQ-GS
$ 88.522 -8.48 ▼ 17,261,958 $ 92.53
$ 88.35
$ 123.37
$ 81.89
7.57 120,995,942
Kite Pharma, Inc.
KITE: NASDAQ-GS
$ 46.3299 -0.28 ▼ 176,128 $ 47.625
$ 45.86
$ 89.84
$ 38.41
NE 2,262,752
Neurocrine Biosciences, Inc.
NBIX: NASDAQ-GS
$ 45.12 -1.78 ▼ 241,523 $ 47.475
$ 45.09
$ 58.46
$ 31.25
NE 3,900,759
bluebird bio, Inc.
BLUE: NASDAQ-GS
$ 44.21 -0.88 ▼ 351,511 $ 45.26
$ 44
$ 197.35
$ 37.40
NE 1,632,587
Juno Therapeutics, Inc.
JUNO: NASDAQ-GS
$ 41.97 -0.07 ▼ 347,530 $ 43
$ 41.50
$ 69.28
$ 22.37
NE 4,367,398
Seattle Genetics, Inc.
SGEN: NASDAQ-GS
$ 35.86 -1.43 ▼ 785,072 $ 37.49
$ 35.17
$ 52.3299
$ 26.02
NE 5,017,997
Spark Therapeutics, Inc.
ONCE: NASDAQ-GS
$ 35.85 -0.65 ▼ 93,929 $ 37.54
$ 35.26
$ 76.24
$ 21.20
NE 970,244
DBV Technologies S.A.
DBVT: NASDAQ-GS
$ 33.78 -0.50 ▼ 25,784 $ 35.205
$ 33.78
$ 44.759
$ 22.5475
NE 1,308,806
Editas Medicine, Inc.
EDIT: NASDAQ-GS
$ 32.236 -1.90 ▼ 83,387 $ 34.55
$ 32.0901
$ 43.99
$ 12.57
NE 1,179,999
Heska Corporation
HSKA: NASDAQ-CM
$ 30.12 -0.49 ▼ 24,897 $ 30.68
$ 29.56
$ 40.29
$ 23.22
40.7 199,876
Acceleron Pharma Inc.
XLRN: NASDAQ-GM
$ 29.845 -0.27 ▼ 141,573 $ 30.20
$ 29.13
$ 50.86
$ 20
NE 1,107,130
Cellectis S.A.
CLLS: NASDAQ-GM
$ 27.39 -0.26 ▼ 29,251 $ 27.72
$ 27.22
$ 50
$ 18
NE 963,553
Repligen Corporation
RGEN: NASDAQ-GS
$ 26.66 -0.31 ▼ 59,047 $ 27.08
$ 26.21
$ 42.48
$ 20.07
91.93 880,633
Acorda Therapeutics, Inc.
ACOR: NASDAQ-GS
$ 25.755 -1.59 ▼ 407,412 $ 27.11
$ 25.11
$ 43.63
$ 24.83
83.08 1,178,265
AveXis, Inc.
AVXS: NASDAQ-GS
$ 23.91 0.91 ▲ 43,878 $ 24.38
$ 22.85
$ 29.63
$ 16.11
NE 549,882
Qiagen N.V.
QGEN: NASDAQ-GS
$ 22.37 -0.34 ▼ 315,939 $ 22.75
$ 22.35
$ 28.53
$ 20.10
43.86 5,213,306
Eiger BioPharmaceuticals, Inc.
EIGR: NASDAQ-GM
$ 20.6272 -0.44 ▼ 2,052 $ 21.062
$ 20.59
$ 41.4041
$ 12.9013
NE 144,762
Coherus BioSciences, Inc.
CHRS: NASDAQ-GM
$ 18.485 -0.77 ▼ 67,237 $ 19.215
$ 18.40
$ 38.10
$ 12.04
NE 722,819
La Jolla Pharmaceutical Company
LJPC: NASDAQ-CM
$ 17.93 -0.77 ▼ 31,652 $ 18.95
$ 17.70
$ 44.9899
$ 12.68
NE 327,294
TrovaGene, Inc.
TROVU: NASDAQ-CM
$ 17.69 unch n/a
n/a
$ 32.69
$ 13.30
NE 20,344
Cellular Biomedicine Group, Inc.
CBMG: NASDAQ-GM
$ 17.55 -0.13 ▼ 6,587 $ 17.65
$ 17.55
$ 41.7299
$ 10.44
NE 210,319